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Stephanie M Topp,b Nathan Kapata,c Helen Ayles,d Chisela Chileshe,e German Henostrozab & Stewart E Reida
Introduction
The United Nations has stated that prisoners are entitled to 
receive health care of a similar standard to that received by 
non-prisoners.1 However, substandard health care and a high 
burden of illness remain common features of prisons in low- 
and middle-income countries.2–4 In Zambia’s prison popula-
tion, prevalence of human immunodeficiency virus (HIV) 
and tuberculosis are believed to be far higher than national 
estimates – of 12.7% and 0.35%, respectively.5–7 According 
to the most recent estimates – done more than 10 years ago 
– 27% of Zambian prisoners are HIV-positive8 and 4% are 
bacteriologically positive for tuberculosis.9
In 2010, the Zambia Prisons Service, Zambia’s national 
tuberculosis and leprosy control programme and the Centre 
for Infectious Disease Research in Zambia jointly imple-
mented the Enhancing TB Services in Zambian Prisons 
project, which was designed to maximize the detection of 
tuberculosis and HIV-infected people in six of Zambia’s 
86 prisons. These prisons were chosen – by project staff in 
consultation with the Zambia Prisons Service – based on 
their population size, historical tuberculosis burden and 
proximity to the capital city of Lusaka (Table 1). Together, 
the six prisons held 30% of Zambia’s prisoners. Funding 
limitations prevented inclusion of all of the prisons in 
Zambia. This paper describes the implementation and 
results of the project. Details of the screening algorithms 
used and prevalence of HIV and tuberculosis recorded at 
one of the prisons covered by the project have already been 
published.10
Methods
The TB REACH initiative of the Stop TB Partnership financed 
the project via a grant of 1 million United States dollars.11 
Although the project began in October 2010 and lasted for 12 
months – covering 3 months of training and sensitization and 
9 months of screening – it was preceded by 6 months of regu-
latory approval, planning, and procurement and 12 months 
of facility renovations. The implementation team consisted 
of 27 project staff: two clinical officers, ten HIV counsellors, 
one project coordinator, one assistant project coordinator, six 
nurses, one community outreach coordinator, two laboratory 
technicians, two microscopists and two radiographers.
The project had four main objectives: (i) to improve 
infection control and diagnostic capacity, (ii) to strengthen 
awareness of tuberculosis in the prison environment, (iii) to 
develop better systems for the screening of new inmates and 
the referral of those who became symptomatic while incarcer-
ated, and (iv) to diagnose all tuberculosis and HIV infections, 
by conducting a single mass screening in the prisons and 
community-based screening in the encampments – and then 
refer patients for treatment. Activities were implemented in 
several phases across the different prison facilities and encamp-
ments. The total target population comprised 4700 inmates 
and 3000 encampment residents.
Objective To improve the Zambia Prisons Service’s implementation of tuberculosis screening and human immunodeficiency virus (HIV) 
testing.
Methods For both tuberculosis and HIV, we implemented mass screening of inmates and community-based screening of those residing 
in encampments adjacent to prisons. We also established routine systems – with inmates as peer educators – for the screening of newly 
entered or symptomatic inmates. We improved infection control measures, increased diagnostic capacity and promoted awareness of 
tuberculosis in Zambia’s prisons.
Findings In a period of 9 months, we screened 7638 individuals and diagnosed 409 new patients with tuberculosis. We tested 4879 
individuals for HIV and diagnosed 564 cases of infection. An additional 625 individuals had previously been found to be HIV-positive. 
Including those already on tuberculosis treatment at the time of screening, the prevalence of tuberculosis recorded in the prisons and 
adjacent encampments – 6.4% (6428/100 000) – is 18 times the national prevalence estimate of 0.35%. Overall, 22.9% of the inmates and 
13.8% of the encampment residents were HIV-positive.
Conclusion Both tuberculosis and HIV infection are common within Zambian prisons. We enhanced tuberculosis screening and improved 
the detection of tuberculosis and HIV in this setting. Our observations should be useful in the development of prison-based programmes 
for tuberculosis and HIV elsewhere.
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Infection control and diagnostic 
capacity
Before the project was launched, no 
prison in Zambia had specific mea-
sures for infection control or any onsite 
capacity for diagnosing tuberculosis. 
Typically, prisoners with tuberculosis 
were held in a sick-cell with other ill 
inmates – including those with mental 
illness or HIV infection. We constructed 
a 20-bed tuberculosis isolation facility in 
Lusaka Central Prison, our most over-
crowded facility. At three prisons, we 
renovated existing structures to create 
permanent onsite microscopy labora-
tories equipped with Primo Star iLED 
fluorescence microscopes (Carl Zeiss 
Microimaging, Oberkochen, Germany). 
To facilitate mass and community-based 
screening, we purchased a 6.1-m long 
semi-mobile container that had been 
custom-fitted for fluorescence micros-
copy and digital chest X-ray (Oldelft 
Benelux, Veenendaal, Netherlands).
Tuberculosis awareness
To improve awareness and prevention 
of tuberculosis among inmates, prison 
personnel and encampment residents, 
we conducted educational outreach 
and training activities (Table 2). These 
included performances by drama groups, 
didactic presentations and door-to-door 
canvassing in the encampments. To dem-
onstrate their support, prison officers-
in-charge participated in these events.
As the Zambia Prisons Service has 
a critical shortage of health personnel, 
project staff trained three groups of 
individuals to recognize individuals 
who have tuberculosis symptoms and 
to screen or refer such individuals for 
care. The three groups trained were: 
(i) lay prison personnel and members 
of neighbourhood health committees; 
(ii) inmate peer educators; and (iii) pris-
on officers – one per prison – who were 
selected as site coordinators.
In each prison, inmate peer edu-
cators were selected by the officer-in-
charge, through an internal process that 
did not involve the project implementa-
tion team. They were often previously 
trained as peer educators for HIV and 
granted greater responsibility within 
the prison hierarchy because of good 
behaviour.
Routine entry screening and 
referral
All convicted inmates and remandees 
sent to Zambian prisons should be 
given a general physical assessment 
upon prison entry. However, such as-
sessment is frequently missed because of 
human-resource and other constraints. 
We used inmate peer educators and 
prison personnel to implement a rou-
tine tuberculosis screening protocol 
for all incoming prisoners regardless of 
symptoms and a referral protocol for in-
mates who developed any cough, fever, 
night sweats and/or weight loss while 
incarcerated (Table 3). The peer edu-
cators were trained to identify new or 
symptomatic inmates, complete screen-
ing data collection forms and observe 
the collection of two morning sputum 
specimens from each inmate. The speci-
mens were examined with fluorescence 
Table 1. Targeted populations for tuberculosis screening and human immunodeficiency 
virus testing, by prison site, Zambia, 2010–2011
Prison site Description Target  
population,  
no.
Lusaka Central Prison Medium security 1300
Livingstone Central Prison Medium security 800
Kabwe Prison Complex The complex consists of 
four prisons: one maximum 
security, one medium 
security, one for female 
prisoners and one low-
security farm
2600
Encampments adjacent to the Lusaka 
Central Prison and Kabwe Prison Complex
Occupied by prison 
personnel and their families
3000
Table 2. Educational outreach and training for tuberculosis screening and human immunodeficiency virus testing in Zambian prisons, 
2010–2011
Targeted population Activity No. of 
individuals 
reached
Description
Educational 
outreach
Implementation 
training
All prison personnel, other 
encampment residents and 
inmates
Yes No 14 736a Outreach events held within prisons and adjacent 
encampments to introduce project and inform about 
ongoing screening activities
Selected prison personnel 
and selected other 
encampment residents
No Yes 136 Training and retraining, 1–3 days, for those prison 
personnel and members of neighbourhood health 
committees who will assist with screening 
Selected inmates No Yes 197 Training and retraining, 2–5 days, for the inmate peer 
educators who will assist with tuberculosis screening 
and for inmates in the drama groups who will assist with 
outreach
Prison clinicians and nurses No Yes 43 Training, 3–5 days, in the provision of HIV care and 
treatment, interpretation of chest X-rays and TB case 
documentation
HIV: human immunodeficiency virus; TB: tuberculosis.
a  Including inmates (n = 8911), prison officers, their families and other prison staff.
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microscopy by a trained laboratory 
technician either at a newly renovated 
microscopy laboratory or at the closest 
Ministry of Health clinic. Any inmate 
found smear-positive for tuberculosis 
or smear-negative and symptomatic was 
taken to the nearest Ministry of Health 
clinic for the initiation of anti-tubercu-
losis treatment and, on some occasions, 
further investigation. Provision of HIV 
testing and counselling varied by site, 
depending on the availability of test kits 
and trained counsellors.
Tuberculosis treatment at the Min-
istry of Health clinics was provided by 
the national tuberculosis and leprosy 
control programme, using existing reg-
istration and treatment procedures. 
Inmates found smear-positive were 
isolated in a designated cell or, at Lusaka 
Central Prison, in the new tuberculosis 
isolation facility and assessed weekly 
by smear microscopy. They returned 
to the general prison population when 
smear-negative.
Mass and community-based 
screening
To determine the extent of tuberculosis 
and HIV disease among the inmates – 
and to ensure all infected individuals 
were diagnosed and received treat-
ment – we conducted mass tubercu-
losis screening and HIV testing at five 
prisons. One prison was omitted from 
this phase because of limited time and 
funding. Because of poor infection-
control procedures within the prisons 
and the close contact between inmates 
and prison personnel, we also conducted 
community-based screening in the 
encampments where prison personnel 
and their families were living (Table 3).
During mass screening, the imple-
mentation team was assisted by trained 
lay prison personnel, inmate peer 
educators and members of the local 
neighbourhood health committees. 
Tents were used as temporary screen-
ing stations. Once every inmate in a 
prison had been screened, the entire 
operation – i.e. the tents, semi-mobile 
container and project staff – moved 
into the adjacent encampment for the 
community-based screening.
Within the prisons, inmate peer 
educators sensitized and organized in-
mates in groups of up to 50 individuals, 
observed collection of two morning spu-
tum samples, led groups through pretest 
counselling for HIV, guided smaller 
groups through the screening stations 
and completed data collection forms. 
Members of neighbourhood health 
committees proceeded door-to-door in 
the encampments to educate residents 
about the available screening services 
and initiate screening procedures. Al-
though the inmates’ participation in 
tuberculosis screening was compulsory, 
that of prison personnel and other en-
campment residents was voluntary.
For each individual screened, it 
took 2 days to test and provide results. 
All participants proceeded through 
separate screening stations to provide 
a symptom history, have a digital chest 
X-ray taken and undergo HIV counsel-
ling and testing. In the final screening 
station, a clinical officer performed 
physical examinations and reviewed 
symptoms, X-rays, HIV status and 
smear microscopy results. Every in-
mate provided two sputum samples, 
regardless of their symptoms. However, 
encampment residents were only asked 
to provide two sputum samples if they 
presented with at least one tuberculosis-
related sign or symptom – including 
cough, fever, night sweats, or weight 
loss – or showed an X-ray abnormality 
consistent with tuberculosis – or both.
All sputum samples were examined 
by fluorescence microscopy and one 
sputum sample per individual was in-
oculated in liquid media (BD BACTEC 
MGIT 960 mycobacteria testing system, 
Sparks, United States of America) and on 
solid BBL Lowenstein–Jensen medium 
Table 3. Summary of procedures for tuberculosis screening and human immunodeficiency virus testing in, Zambian prisons, 2010–2011
Intervention Targeted population Prison site Proceduresa
Lusaka 
Central
Kabwe 
Complex
Livingstone 
Central
Routine entry 
screening and 
referral screeningb
All incoming prisoners 
and those who 
developed symptoms 
while incarcerated
Yes Yes Yes Collection of two early-morning spot samples of 
sputum for FM, recording of tuberculosis history, 
exposure and symptoms, opt-out HIV testing, and 
physical examination by clinical officer
Mass screening and 
comprehensive entry 
screeningc
All inmates Yes Yes No Collection of two early-morning spot samples of 
sputum for FM, recording of tuberculosis history, 
exposure and symptoms, opt-out HIV testing, 
digital chest X-ray, physical examination by clinical 
officer, culture of one sputum sample, and drug 
susceptibility testing of positive cultures
Community-based 
screening
All prison personnel 
and other encampment 
residents
Yes Yes No Recording of tuberculosis history, exposure and 
symptoms, opt-out HIV testing, digital chest X-ray, 
physical examination by clinical officer plus – if 
symptomatic or with abnormal X-ray – collection 
of two early-morning spot samples of sputum 
for FM, culture of one sputum sample, and drug 
susceptibility testing of positive cultures
FM: fluorescence microscopy; HIV: human immunodeficiency virus.
a  For all of the targeted populations, tuberculosis treatment was provided by the Zambian Ministry of Health. HIV treatment was provided by the Zambian Ministry of 
Health or by a local nongovernmental organization supporting prison health services.
b  HIV testing and physical examinations were not possible in all of the sites.
c  The procedures for the mass screening and comprehensive entry screening procedures were identical while these two types of screening were being implemented 
concurrently. Once the mass screening ended, the algorithm for routine entry and referral screening – rather than that for the comprehensive entry screening – was 
followed.
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(BD Diagnostics). The species and drug 
susceptibility of the Mycobacterium in 
each positive sample were investigated 
in a GenoType MDR line-probe assay 
(Hain Lifescience, Nehren, Germany).
Individuals diagnosed with tu-
berculosis were referred to the nearest 
Ministry of Health clinic for initiation 
of treatment. Individuals who were 
later found to be culture-positive for 
Mycobacterium tuberculosis but not 
previously diagnosed were located, if 
possible, and also referred for treatment. 
Individuals found to have drug-resistant 
tuberculosis who could not be tracked 
by the project team were reported to the 
nearest District Health Office.
Provider-initiated HIV counselling 
and testing were delivered to inmates on 
an opt-out basis. All inmates received 
HIV pretest counselling according to 
Zambian national and World Health 
Organization guidelines. Throughout 
the project, special attention was paid 
to the vulnerable nature of the inmate 
population in the context of opt-out 
testing. Decision to test, testing and 
post-test counselling were conducted in 
private, by trained external counsellors 
who were not affiliated with any prison. 
Individuals tested positive were referred 
for HIV care and treatment either at a 
Ministry of Health clinic or a local non-
governmental organization supporting 
prison health services.
Data collection and analysis
Project-specific forms were used to col-
lect data on demographics, tuberculosis 
and HIV histories, symptoms and results 
of the physical examinations, chest X-
ray and laboratory tests. Project nurses 
and data-entry personnel reviewed these 
forms for completeness before data en-
try. To measure the project’s impact on 
screening for tuberculosis, data on the 
notification of tuberculosis cases in pris-
ons and in encampments for the 3 years 
before the project’s implementation and 
for the 9 months of implementation 
were extracted from the treatment reg-
isters of Zambia’s national tuberculosis 
and leprosy control programme and 
compared. For our data analysis, a tu-
berculosis case was defined as anyone 
who had been found bacteriologically 
positive by fluorescence microscopy 
for acid-fast bacilli or by culture for 
M. tuberculosis or had been clinically 
diagnosed with tuberculosis. Individu-
als who were clinically diagnosed had 
negative or missing microscopy and 
culture results, but received an empiric 
diagnosis of tuberculosis based on pre-
sentation of tuberculosis-related signs 
and symptoms or an X-ray abnormality 
consistent with tuberculosis – or both. 
We calculated the prevalence of 
HIV infection, bacteriologically-positive 
tuberculosis, clinically-diagnosed tuber-
culosis and total tuberculosis. For tuber-
culosis, we compared the case detection 
during the project’s implementation 
with that of the previous 3 years. We also 
compared case detection among inmates 
screened comprehensively upon entry to 
the prison – i.e. on the basis of symptoms, 
fluorescence microscopy, cultures, X-rays 
and physical examinations – with inmates 
screened routinely – i.e. on the basis of 
symptoms and fluorescence microscopy 
only. Prevalences and case detection 
levels were compared using χ2 tests. Data 
analyses were conducted in SAS version 
9.3 (SAS Institute, Cary, USA).
Ethical review
The project was reviewed by the Bio-
medical Research Ethics Committee of 
the University of Zambia (001–03–11) 
and the Institutional Review Board of 
the University of Alabama at Birming-
ham (F101014011). Both institutions 
waived the need for informed consent 
as tuberculosis and HIV screening were 
identified as standard care. An inmate 
representative was present at the Insti-
tutional Review Board of the University 
of Alabama’s meeting when the project’s 
protocol was reviewed.
Results
Project outcomes are shown in Table 4. 
Between January and September 2011, 
we screened a total of 7638 individuals 
for tuberculosis. Eighty-two of these 
individuals were on anti-tuberculosis 
treatment when they were screened. 
We diagnosed an additional 409 new 
patients with tuberculosis: 160 who were 
found bacteriologically positive – by 
fluorescence microscopy or culture or 
both – and 249 who were positive for 
tuberculosis on clinical grounds alone. 
We therefore observed 491 patients with 
active tuberculosis giving an overall 
prevalence of 6428 cases per 100 000 
people (Table 5).
When we stratified the results by 
sex, we found that 1.2% (12/1008) of the 
females screened and 2.2% (148/6630) 
of the males had bacteriologically-pos-
itive tuberculosis. The corresponding 
values for clinically-diagnosed tuber-
culosis were 1.5% (15/1008) and 3.5% 
(234/6630), respectively. The mean age 
of individuals with bacteriologically-
positive tuberculosis was 46 years, with 
clinically-diagnosed tuberculosis it was 
53 years, and with no tuberculosis, 43 
years. Of the 160 individuals found 
bacteriologically positive for tuber-
culosis, one (0.6%) had multidrug-
resistant tuberculosis and four (2.5%) 
had tuberculosis that was resistant to 
isoniazid only.
Between the end of 2007 and end of 
2010 the numbers of diagnosed tubercu-
losis cases stayed fairly stable, however, 
Table 4. Project objectives and outcomes for tuberculosis screening and human 
immunodeficiency virus testing in Zambian prisons, 2010–2011
Main objectives Outcomes
Improve tuberculosis infection 
control and diagnostic capacity
Constructed one tuberculosis isolation facility in 
Lusaka Central Prison, renovated and equipped 
microscopy laboratories at Lusaka Central Prison, 
Livingstone Central Prison and the Kabwe Prison 
Complex, and procured a containerized digital X-ray 
and microscopy laboratory
Strengthen tuberculosis awareness 
among inmates and prison 
personnel and other encampment 
residents
14 736 individuals participated in educational 
outreach and 197 inmate peer educators, 98 prison 
personnel and 38 members of neighbourhood health 
committees were educated about tuberculosis and 
tuberculosis screening procedures
Establish routine entry and referral 
screening for tuberculosis
Screening established in all six prisons and 2401 
inmates were screened routinely
Conduct mass and community-
based tuberculosis screening and 
HIV testing
Mass screening covered the 3929 inmates in five of the 
prisons while community-based screening covered 
1308 of the residents in two encampments
HIV: human immunodeficiency virus.
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these increased while the project was 
implemented (Fig. 1). For example, 138 
cases of tuberculosis were recorded from 
January to September 2010 whereas 409 
were recorded from January to Septem-
ber 2011.
Entry screening
Of 2231 inmates screened as they 
entered prison, 799 received compre-
hensive entry screening while the other 
1432 received routine entry screening 
that only involved the assessment of 
symptoms and the examination of spu-
tum smears by fluorescence microscopy. 
The recorded prevalence of bacterio-
logically-positive tuberculosis (3.6% 
versus 0.3%; P < 0.001) and clinically-
diagnosed tuberculosis (1.8% versus 
0.4%; P < 0.001) were both significantly 
higher with comprehensive screening 
than with routine screening (Table 5).
HIV testing
Most (74%; 4694/6330) inmates and 
most (62%; 810/1308) encampment 
residents agreed to HIV testing or had 
a known prior status (Table 5). Testing 
resulted in 564 individuals (512 inmates 
and 52 encampment residents) being 
newly diagnosed with HIV infection. 
In addition, 625 individuals (565 in-
mates and 60 encampment residents) 
claimed and, in many cases, provided 
documentary evidence to show that 
they had previously been found to be 
HIV-positive. The overall prevalence of 
HIV infection was 22.9% (1077/4694) 
Table 5. Tuberculosis screening and human immunodeficiency testing results in Zambian prisons, 2010–2011
Result Type of screeninga
Mass Community-based Comprehensive 
entry
Routine entry Referral
Tuberculosis
No. screened 3929 1308 799 1432 170
On ATT at time of 
screening
    No. 69 4 6 0 3
    % (95% CI) 1.8 (1.4–2.2) 0.3 (0.1–0.8) 0.8 (0.3–1.6) 0.0 (0.0–0.3) 1.8 (0.4–5.1)
Bacteriologically positive
    No. 111 10 29 5 5
    % (95% CI) 2.8 (2.3–3.4) 0.8 (0.4–1.4) 3.6 (2.4–5.2) 0.3 (0.1–0.8) 2.9 (1.0–6.7)
Clinically diagnosed
    No. 178 20 14 6 31
    % (95% CI) 4.5 (3.9–5.2) 1.5 (0.9–2.4) 1.8 (1.0–2.9) 0.4 (0.2–0.9) 18.2 (12.7–24.9)
All cases
    No. 358 34 49 11 39
    % (95% CI) 9.1 (8.2–10.1) 2.6 (1.8–3.6) 6.1 (4.6–8.0) 0.8 (0.4–1.4) 22.9 (16.9–30.0)
HIV
No. positive (tested) 907 (3691) 112 (810) 99 (504) 45 (372) 26 (127)
% positive (95% CI) 24.6 (23.2–26.0) 13.8 (11.5–16.4) 19.6 (16.3–23.4) 12.1 (9.0–15.9) 20.5 (13.8–28.5)
ATT: anti-tuberculosis therapy; CI: confidence interval; HIV: human immunodeficiency virus.
a  The procedures for the mass screening and comprehensive entry screening procedures were identical while these two types of screening were being implemented 
concurrently. Once the mass screening ended, the algorithm for routine entry and referral screening – rather than that for the comprehensive entry screening – was 
followed.
Fig. 1. Numbers of tuberculosis cases recorded among inmates at six prisons and 
residents at two encampments, Zambia, 2007–2011
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Note: Persons with sputum samples that tested positive for tuberculosis by microscopy or culture were 
defined as bacteriologically positive. Total tuberculosis cases include bacteriologically-positive and 
clinically-diagnosed tuberculosis patients. Individuals who were clinically diagnosed had negative or 
missing microscopy and culture results, but received an empiric diagnosis of tuberculosis because they 
presented with at least one tuberculosis-related sign or symptom or showed an X-ray abnormality 
consistent with tuberculosis – or both.
Data source: Zambia’s national tuberculosis and leprosy control programme.
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among the inmates, 13.8% (112/810) 
among the encampment residents, 37% 
(49/132) among the individuals with 
bacteriologically-positive tuberculosis, 
37% (80/214) among the individuals 
with clinically-diagnosed tuberculosis, 
and 20% (1006/5081) among the indi-
viduals without tuberculosis.
Tuberculosis treatment follow-up
Of the 409 individuals newly diagnosed 
with tuberculosis, 372 (91%) were re-
corded as initiating tuberculosis treat-
ment. Of those who initiated treatment, 
238 (64%) had a documented cure or 
treatment completion, 20 (5%) died, and 
seven (2%) defaulted. The remaining 107 
(29%) had unknown outcomes because 
of their release from prison (n = 39), 
transfer to another prison (n = 47) or 
another reason (n = 21).
Discussion
Mirroring the findings from prison 
studies in Cameroon, Côte d’Ivoire, 
Malawi, South Africa2,12–15 and several 
non-African countries,16,17 our results 
indicate that HIV infection and tu-
berculosis are more common within 
prisons than in the general population. 
In the targeted prisons and surrounding 
encampments, the prevalence of tuber-
culosis was 18 times higher than the 
Zambian national estimate.6 Similarly, 
HIV prevalence among the inmates we 
screened was nearly twice the Zambian 
national estimate.5
The Zambian prison health system 
has historically lacked the resources and 
capacity needed to implement rigorous 
screening, diagnosis and treatment 
measures for communicable diseases 
among inmates.18–20 The Enhancing TB 
Services in Zambian Prisons project 
demonstrates that – despite the multiple 
challenges of operating in the prisons 
of a lower middle-income country – a 
range of interventions can effectively 
enhance screening for tuberculosis and 
case detection for both tuberculosis 
and HIV. Although mass screening is 
resource-intensive and probably only 
possible on a periodic basis, we were 
able to test 3929 inmates and 1308 
encampment residents in a 9-month 
period. In low-resource settings – where 
routine screening may otherwise be 
lacking – mass screening has value. The 
project also demonstrated the potential 
of more systems-oriented activities to 
address the chronic shortages of human 
resources for health in prisons – most 
notably the training and mobilizing of 
inmates as peer educators. The pres-
ence of trained inmate peer educators 
enabled the Zambia Prisons Service to 
overcome several barriers – e.g. lack of 
health personnel for routine symptom 
screening – and facilitated referrals and 
adherence support for those receiving 
treatment for HIV, tuberculosis or both 
infections.
During project implementation, sev-
eral programmatic and clinical challenges 
were encountered. Despite the confined 
setting, loss of inmates to follow-up – 
both between tuberculosis diagnosis and 
treatment and during tuberculosis treat-
ment – was a problem, primarily because 
the prisons had ineffective systems for 
tracking inmates once they had been 
released or transferred to other facilities. 
Despite strong support from the highest 
levels of the Zambia Prisons Service, 
the project also encountered resistance 
from some prison personnel, who saw 
the introduction of some activities – no-
tably the routine entry screening and the 
supervision of inmate peer educators – as 
additional work for which they received 
no compensation. The recognition and 
mitigation of such resistance will be 
critical to the sustainability of most of 
the project’s activities.
As reported in other settings,21 
the low sensitivity of the tools com-
monly used for tuberculosis screen-
ing and diagnosis was a challenge to 
the timely diagnosis of tuberculosis 
and, therefore, also a challenge to the 
timely initiation of treatment. In one 
of the prisons covered by the project, 
only 25% (22/88) of the patients with 
culture-positive tuberculosis were found 
sputum-smear-positive by fluorescence 
microscopy and 33% (29/88) of these 
patients never reported any symptoms.10 
Such findings caution against the use of 
screening algorithms that triage inmates 
on the basis of their symptoms or smear 
results and they also highlight the need 
for more sensitive diagnostic tools. For 
prison and general populations alike, a 
rapid, accurate, point-of-care tool for 
the diagnosis of tuberculosis is urgently 
required – both to help curtail the dis-
ease’s spread and reduce its associated 
mortality.22
Since the project ended, the Zam-
bia Prisons Service has continued 
routine entry and referral tuberculosis 
screening – with funding and ongoing 
technical assistance from the Centre for 
Infectious Disease Research in Zambia. 
Further assessment to understand the 
long-term cost of establishing routine 
screening – including the cost of train-
ing and supervising the inmate peer 
educators – is needed. However, the 
project showed that inmates can support 
better health-service delivery within 
Box 1. Designing prison programmes to screen for tuberculosis and test for human 
immunodeficiency virus
•	 Engage high-level prison officials to facilitate buy-in of prison officers-in-charge and give 
legitimacy to the project.
•	 Secure start-up funding for monitoring, training, equipment, supplies and logistical support.
•	 Assess the capacity of – and strengthen – the existing care and treatment programmes, so 
that such programmes can cope with the additional cases detected.
•	 Consider carefully the ability of existing infrastructure to support infection control and 
onsite diagnostic capacity, while recognizing that renovations can be expensive and require 
a long time to complete.
•	 Train and empower inmates as peer educators who can conduct outreach and screening 
procedures, and develop peer-to-peer mentoring to maintain the cadre.
•	 Train prison personnel to supervise the inmate peer educators and facilitate their access to 
screening supplies and space.
•	 Prioritize the development of rapid and sensitive tools for tuberculosis diagnosis – within 
prisons and elsewhere.
•	 Conduct opt-out human immunodeficiency virus testing and counselling for all individuals 
screened for tuberculosis.
•	 Conduct entry and referral screening, with periodic screening at release, to assess the 
effectiveness of the interventions – instead of mass screening, which is resource-intensive.
•	 Encourage prison personnel and encampment residents to access tuberculosis screening, 
diagnosis, treatment and care.
•	 Develop a strategy to secure dedicated support and funding to promote sustainable, 
integrated health care for inmates.
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prisons and that one-off mass screenings 
can be used to establish prevalence and 
initiate treatment. Descriptions of the 
project’s activities and findings also pro-
vide a basis for the adaptation of similar 
programmes in other prison services. 
Components that appeared critical to 
the success of the project’s activities are 
outlined in Box 1.
The project – and our investiga-
tion of it – had several limitations. The 
activities and findings reported here are 
from only six prisons and may not be 
generalizable to all Zambian prisons. We 
may have underestimated tuberculosis 
prevalence because suboptimal sputum 
quality led to high frequencies of cul-
ture contamination.23 We had difficulty 
diagnosing extrapulmonary tuberculosis 
and we relied solely on fluorescence mi-
croscopy during routine entry screening. 
Conversely, the clinical misdiagnosis of 
tuberculosis in individuals who had other 
pulmonary disease may have led to tuber-
culosis prevalence being overestimated.
Conclusion
In Zambia, many prisoners have tubercu-
losis, HIV infection or both, and various 
screening and treatment interventions 
could be implemented to reach a large num-
ber of prisoners in a comparatively short 
time. Our findings should act as a catalyst 
for improving prison services for the detec-
tion and treatment of tuberculosis and HIV 
infection in Zambia and elsewhere. ■
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صخلم
ايبماز في نوجسلا في يشربلا يعانلما زوعلا سويرف رابتخاو لسلا يرتح
 يعانلما  زوعلا  سويرف  رابتخاو  لسلا  يرتح  ذيفنت  ينستح  ضرغلا
.ايبماز في نوجسلا ةحلصم لبق نم يشربلا
 يعانلما  زوعلا  سويرفو  لسلا  نم  لكب  قلعتي  مايف  ،انمق  ةقيرطلا
 قاطن  لىع  يرتحو  ،ءانجسلل  قاطنلا  عساو  يرتح  ذيفنتب  ،يشربلا
 ةخماتم  تاركسعم  في  نوميقي  نيذلا  صاخشلأل  ليحلما  عمتجلما
 ءلازنلا اهيف علطضا - ةينيتور مظن ءاشنإب كلذك انمقو .نوجسلل
 ميهدل دجوت نم وأ ددلجا ءلازنلا يرتح لجأ نم - مهئلامز فيقثتب
 ةردقلا  ةدايزو  ىودعلا  ةحفاكم  يربادت  ينسحتب  انمقو  .ضارعأ
.ايبماز في نوجسلا في لسلاب يعولا زيزعتو ةيصيخشتلا
 صيخشتو ًاصخش 7638 يرحتب رهشأ 9 ةترف للاخ انمق جئاتنلا
 يعانلما زوعلا سويرف رابتخا انيرجأو .لسلاب ًاديدج ًاضيرم 409
 .ةباصإ  ةلاح  564  صيخشتب  انمقو  ًاصخش  4879  لىع  يشربلا
 يشربلا يعانلما زوعلا سويرفل نيرخآ ًاصخش 625 ةيبايجإ ينبتو
 نوجسلا في هليجست مت يذلا لسلا راشتنا لدعم ناكو .قباسلا في
 فعض 18 - )100000/6428( % 6.4 - ةخماتلما تاركسعلماو
 .%  0.35  غلب  يذلا  ينطولا  ديعصلا  لىع  راشتنلاا  ىدم  ريدقت
 صاخشلأا نم % 13.8و ءلازنلا نم % 22.9 ناك ،ماع لكشبو
 يعانلما  زوعلا  سويرفل  ينيبايجإ  تاركسعلما  في  نوميقي  نيذلا
.يشربلا
 يعانلما زوعلا سويرف ىودعو لسلا نم لك راشتنا عيشي جاتنتسلاا
 ينستحو لسلا  يرتح زيزعتب  انمقو  .ايبماز  في نوجسلا  في يشربلا
 يغبنيو .ةئيبلا هذه في يشربلا يعانلما زوعلا سويرفو لسلا فشك
 صوصخب  نوجسلل  جمارب  عضو  في  انتاظحلام  نم  ةدافتسلاا
.ىرخأ قطانم في يشربلا يعانلما زوعلا سويرفو لسلا
摘要
赞比亚监狱结核病筛查和艾滋病病毒检测
目的 改进赞比亚监狱服务部门对结核病筛查和艾滋病
病毒（HIV）检测的实施。
方法 在结核病和艾滋病方面，我们都执行了大规模犯
人筛查，并对监狱附近营地居民实施以社区为基础的
筛查。我们还建立了常规系统，让狱友作为同伴教育
者，筛查新入狱或有症状的囚犯。我们改进感染控制
措施，增强诊断能力，提升赞比亚监狱结核病意识。
结果 在 9 个月的时间中，我们筛选了 7638 名个人并
诊断 409 例新结核病患者。我们对 4879 位个人进行艾
滋病毒检测并诊断出 564 例感染。另外还有 625 人曾
经检查出艾滋病毒阳性。包括那些在筛查时已经在接
受结核病治疗的人，在监狱和邻近营地记录的肺结核
患病率达 6.4%（6428/10 万人），这是全国发病率估算
值 0.35% 的 18 倍。总体来看，22.9% 的囚犯和 13.8%
的营地居民是艾滋病毒阳性。
结论 结核病和艾滋病毒感染在赞比亚监狱都是常见
的。我们加强结核病筛查并改善在此环境中的结核病
和艾滋病毒的检测。我们的观察对于在其他地方制定
基于监狱的结核病和艾滋病计划应该会有帮助。
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Résumé
Dépistages de la tuberculose et du virus de l’immunodéficience humaine dans les prisons zambiennes
Objectif Améliorer la mise en œuvre des dépistages de la tuberculose 
et du virus de l’immunodéficience humaine (VIH) de l’Administration 
pénitentiaire de la Zambie.
Méthodes Nous avons mis en œuvre les dépistages de masse à la 
fois pour la tuberculose et le VIH chez les détenus et le dépistage 
communautaire des personnes résidant dans les campements adjacents 
aux prisons. Nous avons également établi des systèmes de routine – 
en utilisant les détenus pour éduquer leurs pairs – pour le dépistage 
des nouveaux détenus ou des détenus symptomatiques. Nous avons 
amélioré les mesures de contrôle des infections, augmenté la capacité 
diagnostique et promu la sensibilisation à la tuberculose dans les 
prisons de Zambie.
Résultats Pendant une période de 9 mois, nous avons testé 
7638 personnes et diagnostiqué 409 nouveaux patients atteints 
de tuberculose. Nous avons testé 4879 personnes pour le VIH et 
diagnostiqué 564 cas d’infection. En outre, 625 personnes avaient déjà 
été préalablement dépistées comme étant séropositives pour le VIH. 
En tenant compte des personnes déjà traitées contre la tuberculose au 
moment du dépistage, la prévalence de la tuberculose rapportée dans 
les prisons et les campements adjacents – 6,4% (6428/100 000) – est 18 
fois supérieure à l’estimation de la prévalence nationale de 0,35%. Dans 
l’ensemble, 22,9% des détenus et 13,8% des individus résidant dans les 
campements étaient séropositifs pour le VIH.
Conclusion Les infections par la tuberculose et le VIH étaient courantes 
dans les prisons zambiennes. Nous avons amélioré le dépistage de 
la tuberculose et la détection de la tuberculose et du VIH dans ces 
conditions. Nos observations devraient être utiles pour développer 
les programmes pénitentiaires de lutte contre la tuberculose et le VIH 
ailleurs dans le monde.
Резюме
Скрининг на туберкулез и тестирование на вирус иммунодефицита человека в тюрьмах Замбии
Цель Повысить эффективность проведения скрининга на 
туберкулез и тестирования на вирус иммунодефицита человека 
(ВИЧ) в пенитенциарной службе Замбии.
Методы Как для туберкулеза, так и ВИЧ был проведен массовый 
скрининг заключенных и жителей, проживающих в лагерных 
поселениях, прилегающих к тюрьмам. Также были организованы 
постоянно действующие мероприятия — где в роли 
просветителей выступали сами заключенные — для скрининга 
вновь поступивших заключенных или тех, у кого имелись 
соответствующие симптомы. В результате удалось добиться 
улучшения системы инфекционного контроля, повышения 
диагностического потенциала и роста осведомленности о 
туберкулезе в тюрьмах Замбии.
Результаты За период 9 месяцев был проведен скрининг 
7638 лиц и диагностировано 409 новых случаев туберкулеза. 
Также было протестировано 4879 лиц на наличие ВИЧ и 
диагностировано 564 случая этого заболевания. Еще 625 лиц 
показали положительный результат анализа на ВИЧ ранее. 
Включая тех лиц, кто уже проходил лечение от туберкулеза 
во время проведения обследования, распространенность 
туберкулеза, зарегистрированная в тюрьмах и смежных с 
ними лагерных поселениях, составила 6,4% (6428/100 000), 
что в 18 раз превышало общенациональную статистику по 
распространенности данного заболевания на уровне 0,35%. В 
целом, 22,9% заключенных и 13,8% жителей соседних лагерных 
поселений являлись ВИЧ-инфицированными.
Вывод Как туберкулез, так и ВИЧ-инфекция являются 
распространенными заболеваниями в тюрьмах Замбии. Были 
усилены меры по обследованию заключенных на туберкулез 
и улучшено обнаружение туберкулеза и ВИЧ-инфекции в этих 
условиях. Эти наблюдения должны быть полезны при разработке 
программ по выявлению туберкулеза и ВИЧ-инфекции в тюрьмах 
и других местах.
Resumen
Detección de la tuberculosis y pruebas del virus de la inmunodeficiencia humana en las prisiones de Zambia
Objetivo Mejorar la aplicación del servicio de prisiones de Zambia 
de detección de la tuberculosis y las pruebas del virus de la 
inmunodeficiencia humana (VIH).
Métodos Para la tuberculosis y el VIH, se llevó a cabo una detección 
masiva de reclusos y la detección comunitaria de aquellos que residían 
en campamentos adyacentes a las prisiones. También se establecieron 
sistemas rutinarios para la detección de los reclusos recién ingresados 
o sintomáticos en los que los reclusos actuaban como educadores de 
sus compañeros. Se mejoraron las medidas de control de la infección, 
se aumentó la capacidad diagnóstica y se promovió el conocimiento 
de la tuberculosis en las prisiones de Zambia.
Resultados En un periodo de 9 meses, se examinó a 7638 personas y se 
diagnosticó tuberculosis a 409 pacientes nuevos. Se realizaron pruebas 
del VIH a 4879 personas y se diagnosticaron 564 casos de infección. 
Previamente se había hallado que otras 625 personas era VIH positivas. 
Teniendo en cuenta aquellas personas que ya estaban en tratamiento 
para la tuberculosis en el momento de la detección, la prevalencia de la 
tuberculosis en las prisiones y los campamentos adyacentes, a saber, 6,4 
% (6428/100 000), es 18 veces la estimación de la prevalencia nacional 
de 0,35 %. En total, el 22,9 % de los reclusos y el 13,8 % de los residentes 
del campamento eran VIH-positivos.
Conclusión Tanto la tuberculosis como la infección por VIH son 
comunes en las prisiones de Zambia. Se consiguió mejorar la detección 
de la tuberculosis y del VIH en este contexto, y esperamos que nuestras 
observaciones sean útiles para el desarrollo de programas de prisión de 
la tuberculosis y el VIH en otros contextos.
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